Nuvectis Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NVCT and other ETFs, options, and stocks.About NVCT
Nuvectis Pharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology. Its product pipeline includes NXP800 and NXP900.
CEORonald E. Bentsur
CEORonald E. Bentsur
Employees13
Employees13
HeadquartersFort Lee, New Jersey
HeadquartersFort Lee, New Jersey
Founded2020
Founded2020
Employees13
Employees13
NVCT Key Statistics
Market cap199.94M
Market cap199.94M
Price-Earnings ratio-5.75
Price-Earnings ratio-5.75
Dividend yield—
Dividend yield—
Average volume109.35K
Average volume109.35K
High today$7.76
High today$7.76
Low today$7.26
Low today$7.26
Open price$7.58
Open price$7.58
Volume76.33K
Volume76.33K
52 Week high$11.52
52 Week high$11.52
52 Week low$4.44
52 Week low$4.44
Stock Snapshot
Nuvectis Pharma(NVCT) stock is priced at $7.59, giving the company a market capitalization of 199.94M. It carries a P/E multiple of -5.75.
On 2025-12-15, Nuvectis Pharma(NVCT) stock traded between a low of $7.26 and a high of $7.76. Shares are currently priced at $7.59, which is +4.5% above the low and -2.1% below the high.
The Nuvectis Pharma(NVCT)'s current trading volume is 76.33K, compared to an average daily volume of 109.35K.
During the past year, Nuvectis Pharma(NVCT) stock moved between $4.44 at its lowest and $11.52 at its peak.
During the past year, Nuvectis Pharma(NVCT) stock moved between $4.44 at its lowest and $11.52 at its peak.
People also own
Based on the portfolios of people who own NVCT. This list is generated using Robinhood data, and it’s not a recommendation.